Skip to content
Home - Clinical trials - Diprivan™ (propofol)    
Diprivan™ (propofol) Clinical Trial report summaries

Diprivan™ (propofol) is an injectable general anaesthetic for the induction and maintenance of anaesthesia

Diprivan™ (propofol) is also approved in most markets for use in the sedation of mechanically ventilated intensive care adult patients and the sedation of patients undergoing diagnostic or surgical procedures.  

Please consult the prescribing information for the country concerned for guidance on the approved use of Diprivan™ (propofol).

Study Number Completed Clinical Trial Report Summaries

0859IL/0068

A Multicenter, Comparative, Randomized Trial to Determine the Overall Safety and Efficacy of 1% Diprivan] vs 2% Diprivan vs Standard Agents Without Disodium Edetate for Sedation of Trauma, Postsurgical, or Critically Ill Pediatric Subjects.

AstraZeneca websites
Search
Corporate Responsibility
Quick links - Products
Page tools
>
>
>
>